Efficacy of toluidine blue in the diagnosis and screening of oral cancer and pre‐cancer: A systematic review and meta‐analysis
- 1 August 2020
- journal article
- review article
- Published by Wiley in Clinical Otolaryngology
- Vol. 46 (1) , 23-30
Abstract
Aims: The accuracy of toluidine blue (TB) and chemiluminescence for diagnosing oral cancer and pre‐cancer was evaluated.Methods: Two authors (working independently) comprehensively reviewed six databases (PubMed, Cochrane database, Embase, Web of Science, SCOPUS and Google Scholar) from their dates of inception until March 2020. Oral mucosal disorder, as detected by TB, was compared with that detected by chemiluminescence. True‐positive, true‐negative, false‐positive and false‐negative data were extracted for each study. Methodological quality was evaluated using the Quality Assessment of Diagnostic Accuracy Studies tool (ver. 2). The extent of interrater agreement was also assessed.Results: Twenty‐nine prospective and retrospective studies were included. The diagnostic odds ratio (DOR) of TB was 7.017 (95% confidence interval [CI], 4.544; 10.836). The area under the summary receiver operating characteristic curve was 0.766. The correlation between the sensitivity and the false‐positive rate was 0.196, indicating the absence of heterogeneity. TB exhibited moderate interrater reliability (0.6777; 95% CI, 0.43; 0.7455). Compared with chemiluminescence, as used in nine studies, TB had a lower sensitivity (0.659 vs 0.841), but a higher specificity (0.809 vs 0.345), negative predictive value (0.766 vs 0.690) and DOR (10.565 vs 5.203). Compared with clinical examination, as used in four studies, TB method had a higher sensitivity (0.891 vs 0.891), specificity (0.739 vs 0.634), negative predictive value (0.920 vs 0.714) and DOR (28.491 vs 8.526). Subgroup analysis showed that screening for severe dysplasia or more severe disease was significantly more sensitive, but less specific, than screening for all dysplasias.Conclusions: Although the diagnostic accuracy of TB in the diagnostic work‐up of oral cancer and pre‐cancer was higher than that of clinical examination, it was not high enough for TB to reliably be used alone. Instead, it should be combined with chemiluminescence or other diagnostic tools.Keywords
Funding Information
- Ministry of Education (2018R1D1A1B07045421)
- H2020 LEIT Information and Communication Technologies (2018M3A9E8020856, 2019M3A9H2032424, 2019M3E5D5064110)
- Bucheon St. Mary's Hospital
- Catholic University of Korea
This publication has 30 references indexed in Scilit:
- Assessment of oral mucosa in normal, precancer and cancer using chemiluminescent illumination, toluidine blue supravital staining and oral exfoliative cytologyJournal of Oral and Maxillofacial Pathology, 2012
- A comparative analysis of toluidine blue with frozen section in oral squamous cell carcinomaWorld Journal of Surgical Oncology, 2012
- Evaluation of chemiluminescence, toluidine blue and histopathology for detection of high risk oral precancerous lesions: A cross-sectional studyBMC Clinical Pathology, 2012
- The use of toluidine blue in the detection of pre-malignant and malignant oral lesionsJournal of Oral Pathology & Medicine, 2011
- The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesionsInternational Journal of Oral and Maxillofacial Surgery, 2011
- Non-invasive diagnostic tools in early detection of oral epithelial dysplasiaJournal of Clinical and Experimental Dentistry, 2011
- Assessing the usefulness of three adjunctive diagnostic devices for oral cancer screening: a probabilistic approachCommunity Dentistry and Oral Epidemiology, 2010
- Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviewsJournal of Clinical Epidemiology, 2005
- Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesionsInternational Journal of Oral and Maxillofacial Surgery, 2005
- Sensitivity and specificity of OraScan® toluidine blue mouthrinse in the detection of oral cancer and precancerJournal of Oral Pathology & Medicine, 1996